Back to Centiva Capital, LP Centiva Capital, LP

TMCITMCI

Showing 4 of 5 quarters

Position history for Centiva Capital, LPCentiva Capital, LP's holdings in Treace Medical Concepts, Inc.

No. Centiva Capital exited its TMCI (Treace Medical Concepts) position in Q3 2026. Its Q2 2026 13F listed 19,593 shares worth $77,980. Centiva Capital first reported TMCI in Q2 2024 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Exited
0
-100.0%
$00.0%$4.44
0
2026-Q2
Decreased
19,593
-30.8%
$77,9800.0%$3.98
0
2026-Q1
New
28,311
—
$37,9370.0%$1.34
28
2024-Q3
Exited
0
-100.0%
$00.0%$5.77
0

Optional analytics helps us improve. How it’s used